What is the recommended treatment for a patient with suspected typhoid fever, presenting with fever for 2 days, negative Typhidot IgM and IgG tests, and a Widal test result of 1:160 with both H and O positive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Recommendation for Suspected Typhoid Fever

Start empiric antibiotic therapy immediately with azithromycin 20 mg/kg/day (maximum 1g/day) orally for 7 days, or ceftriaxone 50-80 mg/kg/day (maximum 2g/day) IV for 5-7 days if the patient appears severely ill, while obtaining blood cultures before the first antibiotic dose. 1, 2

Diagnostic Interpretation

Your serological test results are unreliable and should not guide treatment decisions:

  • The Widal test lacks sensitivity and specificity and is not recommended for diagnosis of typhoid fever. 3 A titer of 1:160 can occur in healthy individuals in endemic areas and does not confirm acute infection.

  • Negative Typhidot IgM and IgG tests do not rule out typhoid fever, especially only 2 days into illness, as these rapid serological tests have shown mixed results in clinical validation. 3

  • Blood cultures remain the gold standard with 40-80% sensitivity in the first week of symptoms and should be obtained immediately before starting antibiotics. 1, 2

Empiric Treatment Selection

Given only 2 days of fever and the clinical suspicion for typhoid:

  • Azithromycin is the preferred first-line agent for uncomplicated cases, showing 94% cure rates in children with typhoid fever and dramatically lower relapse rates (OR 0.09) compared to ceftriaxone. 2, 4

  • Ceftriaxone should be used for severe presentations including signs of sepsis, inability to tolerate oral medications, or clinical instability requiring hospitalization. 1, 2

  • Avoid fluoroquinolones empirically as over 70% of S. typhi and S. paratyphi isolates are now resistant to this class, particularly from South Asian sources. 3, 1, 4

Treatment Duration Critical Point

Extend treatment to 14 days regardless of which antibiotic is chosen to minimize relapse risk, which occurs in 10-15% of inadequately treated cases. 1, 4 This is essential even though initial courses of 5-7 days show clinical response, as:

  • Azithromycin relapse rates are <3% with 14-day courses 1
  • Ceftriaxone relapse rates are <8% with adequate duration 3, 1

Expected Clinical Response

  • Fever should clear within 4-5 days of appropriate therapy. 4, 2

  • If no improvement occurs within 24-48 hours, consider resistant organisms, alternative diagnoses (malaria, dengue, rickettsial infections), or complications. 3, 2

  • Switch from IV to oral therapy once the patient shows clinical improvement and has been afebrile for 24 hours. 2

Antibiotic Susceptibility Testing

When culture results return positive:

  • Request nalidixic acid sensitivity testing, as ciprofloxacin disc testing alone is unreliable for determining fluoroquinolone susceptibility in Salmonella species. 3, 4

  • Narrow therapy based on susceptibility results but maintain the 14-day total duration. 2

Common Pitfalls to Avoid

  • Do not wait for culture confirmation to start antibiotics in clinically suspected cases, as blood culture sensitivity is only 40-80% and delays worsen outcomes. 1

  • Do not rely on the Widal test result of 1:160 to make treatment decisions, as this test is not recommended due to poor diagnostic accuracy. 3

  • Do not use shorter treatment courses (5-7 days only) despite clinical improvement, as this significantly increases relapse rates. 1, 4

  • Do not use cefixime as first-line therapy, as it has reported treatment failure rates of 4-37.6%. 3

References

Guideline

Management of Enteric Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Enteric Fever in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Recurrent Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.